Financials

  • Market Capitalization 7.58 M
  • Employee 8
  • Founded 2017
  • CEO N/A
  • Website www.cnspharma.com
  • Headquarter Nevada, United States
  • FIGI BBG00PM24T16
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.15
Rapporto prezzo/fatturato
-909.61

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4738
CURX
Curanex Pharmaceuticals Inc - Common Stock
4.88 USD-8.10%-4.13%+10.66%+674.60%7.65 M USD
4739
SNGX
Soligenix, Inc. - Common Stock
0.35 USD-2.78%-2.78%-5.41%-69.03%7.62 M USD
4746
INM
InMed Pharmaceuticals Inc. - Common Shares
1.36 USD0.00%-1.45%+5.43%-36.15%7.47 M USD
4748
APRE
Aprea Therapeutics, Inc. - Common Stock
0.59 USD-1.67%-13.24%-23.38%-60.93%7.43 M USD

Notizie